Crimean-Congo haemorrhagic fever
About Crimean-Congo haemorrhagic fever
Crimean-Congo haemorrhagic fever is an emerging pathogen in Europe. Outbreaks have a case fatality rate between 5% and 40%. There is no validated therapy and no safe vaccine.Factsheet, information materials, infographic
Crimean-Congo haemorrhagic fever is endemic in the Balkan region and a few sporadic cases are reported on a regular basis. Latest data is available in the ECDC Annual Epidemiological ReportRead report
Hyalomma marginatum ticks
Hyalomma marginatum is considered to be the most important vector of Crimean-Congo haemorrhagic fever virus in EurasiaRead factsheet
Threats and outbreaks
ECDC assessed the risk associated with the occurrence of two cases of Crimean–Congo haemorrhagic fever in Spain, in 2016.
Surveillance and disease data
Crimean-Congo haemorrhagic fever is endemic in the Balkan region and a few sporadic cases are reported on a regular basis. Latest data from the Annual Epidemiological Report
Prevention and control measures
Prevention and control is achieved by avoiding exposure to infected ticks. Since nosocomial cases are common, strict universal precautions should be taken.
Biosafety standards for working with crimean-congo hemorrhagic fever virus